Physician profile
Christopher D Bane
NPI 1467416578
$20,421.80
in general payments reported to CMS, 2019-2025
53 companies · $2,902 in 2025
The $2,902 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,016 · 2020: $1,745 · 2021: $3,649 · 2022: $3,867 · 2023: $2,788 · 2024: $3,455 · 2025: $2,902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,145.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,302.25 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $2,096.06 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $1,863.38 | 2019-2025 | Farxiga, Lokelma, Wainua |
| Pfizer INC. | $1,727.01 | 2019-2025 | |
| Esperion Therapeutics, INC. | $1,526.06 | 2020-2025 | Nexletol |
| Amgen INC. | $1,200.70 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $886.66 | 2021-2025 | Onyx Frontier, Symplicity G3, Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $823.75 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $720.70 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $709.07 | 2021-2025 | Verquvo, Winrevair |
| Kestra Medical Technology Services, INC. | $550.92 | 2022-2025 | Assure Wcd |
| Novo Nordisk INC | $519.62 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $450.69 | 2019-2025 | Jardiance |
| Chiesi USA, INC. | $400.19 | 2019-2023 | Kengreal |
| Sanofi-Aventis U.S. LLC | $389.95 | 2019-2024 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $329.62 | 2022-2025 | |
| Cardiovascular Systems INC. | $298.33 | 2019-2022 | |
| Boston Scientific Corporation | $265.32 | 2019-2025 | Bodyguardian, Cds - Mct/Cem Monitoring |
| Lexicon Pharmaceuticals, INC. | $204.61 | 2023-2024 | Inpefa |
| Scpharmaceuticals INC. | $197.53 | 2024-2025 | |
| Amarin Pharma, INC. | $180.77 | 2019-2021 | |
| Jenavalve Technology, INC. | $162.44 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $156.51 | 2021-2025 | |
| Cathworks, INC. | $146.32 | 2021 | |
| Penumbra, INC. | $133.44 | 2024 | Penumbra System |
| Lundbeck LLC | $108.91 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $108.32 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $102.94 | 2019-2024 | Evkeeza, Praluent |
| Terumo Medical Corporation | $101.47 | 2019-2024 | Azur Cx Detachable, Glidesheath Slender, Glidewire |
| Akcea Therapeutics, INC. | $54.81 | 2020-2021 | |
| Cleerly, INC. | $52.53 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Alnylam Pharmaceuticals INC. | $51.00 | 2023-2025 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $46.45 | 2024 | Arcalyst |
| Lilly USA, LLC | $41.73 | 2025 | Zepbound, Mounjaro |
| Edwards Lifesciences Corporation | $41.55 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Inspire Medical Systems, INC. | $41.06 | 2023 | Inspire |
| Cook Medical LLC | $40.40 | 2021 | |
| Idorsia Pharmaceuticals US INC | $40.34 | 2025 | Tryvio |
| Kiniksa Pharmaceuticals, LTD. | $37.89 | 2022-2023 | Arcalyst |
| Abbott Laboratories | $37.29 | 2022-2023 | Amplatzer Amulet |
| Cardiva Medical, INC. | $35.34 | 2021 | |
| W. L. Gore & Associates, INC. | $33.66 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Thoracic Branch Endoprosthesis |
| Daiichi Sankyo INC. | $27.74 | 2023 | Injectafer |
| Siemens Medical Solutions USA, INC. | $26.95 | 2025 | |
| Abiomed | $22.75 | 2023 | Impella |
| Teleflex LLC | $19.85 | 2023 | Supercross |
| Elutia, INC. | $16.92 | 2023 | |
| Atricure, INC. | $16.65 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Portola Pharmaceuticals, LLC | $16.03 | 2019 | |
| Tactile Systems Technology INC | $15.76 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.74 | 2020 | |
| Arbor Pharmaceuticals, INC. | $13.70 | 2020 | |
| Medtronic Vascular, INC. | $12.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.